Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin
Abstract
Background: Hematopoietic stem cell transplantation (HSCT) is a critical therapeutic intervention for hematological malignancies. However, infections remain a leading complication. Fluoroquinolones, particularly ciprofloxacin and levofloxacin, are commonly employed as prophylactic agents. This study compares their efficacy in preventing post-HSCT infections.
Methods: A systematic review and meta-analysis were conducted using the Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Relevant studies comparing ciprofloxacin and levofloxacin in HSCT recipients were identified from biomedical databases. Randomized controlled trials and retrospective cohort studies were included. Data extraction encompassed patient demographics, intervention details, and infection outcomes. Meta-analyses employed RevMan software, using risk ratios (RR) and mean differences with 95% confidence intervals (CI).
Results: Five studies involving 1202 HSCT recipients (597 ciprofloxacin; 605 levofloxacin) were analyzed. Levofloxacin showed superior efficacy in reducing bloodstream infections (BSI) (RR = 1.61; 95% CI: [1.04, 2.49]; P = .03) and specifically gram-positive BSI (RR = 1.60; 95% CI: [1.09, 2.36]; P = .02). Both agents demonstrated similar effectiveness in preventing febrile neutropenia (RR = 0.99; P = .96), gram-negative BSI (RR = 0.99; P = .99), pneumonia (RR = 1.24; P = .7), and all-cause mortality (RR = 1.05; P = .7). Hospital stay duration was also…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.